Antitrust Antitrust

Comment: EU raid on Zoetis may have links to antitrust dispute over osteoarthritis drug

By Lewis Crofts and Andrew Boyce
  • 27 Oct 2021 10:58
  • 27 Oct 2021 10:58
This week’s dawn raids by EU antitrust enforcers at the Belgian premises of US animal drug company Zoetis could be linked to a complaint filed by French rival Virbac earlier this year regarding osteoarthritis medicine for dogs.

Zoetis said it was the subject of unannounced inspections on Monday at its Belgian

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Lewis Crofts


Lewis leads MLex's editorial strategy, content direction, quality and development. He has a reputation for breaking stories and providing analysis on complex legal disputes before regulators and courts around the globe. He has also developed MLex's unrivalled coverage of competition policy, litigation, regulation, Brexit and international investigations.

Andrew Boyce


Andrew is a reporter covering merger reviews and competition policy for MLex in Brussels. He joined MLex in 2015 and holds a degree and a master’s degree in history from the University of Liverpool.

Discover MLex

Stay on top of global regulatory developments


Latest News